Recognizing the signs and symptoms that signal the coming of the end ... and platelets that assist in blood clotting are made ...

Dr Dinesh Pendharkar highlights how CAR T–cell therapy is reshaping cancer care in India by equipping the immune system with ...

Mantle cell lymphoma treatment offers options if patients relapse after CAR T-cell therapy, from bispecific antibodies, antibody drug conjugates, and other emerging therapies.

Explore the latest advancements in immunotherapies for T-cell lymphoma, addressing unique challenges and promising new ...

CLL can mean fatigue, fear and years of waiting but new research shows that staying active helps people feel better – and ...

A 27-year-old is five months pregnant and battling stage 4 lymphoma cancer. She credits her baby with helping discover her cancer.

Roche has demonstrated the power of combining two of oncology’s hottest modalities—bispecifics and antibody-drug conjugates (ADCs)—in a Lunsumio-Polivy regimen in large B-cell lymphoma (LBCL ...

The first sign of multiple myeloma varies by person and may not occur until a later stage of the disease. Learn how to ...

Dr. Andre Henri Goy shared how CAR T-cell therapy led a retired pilot with lymphoma into remission, showing the impact of personalized treatment decisions.